By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Nordic Nanovector 

Kjelsåsveien 168 B

  Oslo  0884  Norway
Phone: 47-22-18-33-01 Fax: 47-22-58-00-07


Company News
Nordic Nanovector To Host Capital Markets Day In Oslo On 31 May 2016 5/23/2016 9:39:21 AM
Nordic Nanovector: New Board Members Elected Bringing Further Expertise In The Development And Commercialization Of Innovative Cancer Therapies 5/23/2016 9:00:23 AM
Nordic Nanovector: Annual General Meeting Held 5/19/2016 12:07:38 PM
Nordic Nanovector First Quarter 2016 Results: Strong Progress On All Priorities And Execution On Track 5/19/2016 12:04:10 PM
Nordic Nanovector Announces First Patient Enrolled In The Last Cohort (Arm 4) Of Expanded Phase 1/2 Study Of Betalutin In NHL Patients 5/18/2016 9:19:36 AM
Nordic Nanovector: Proposal From The Nomination Committee To The Annual General Meeting 19 May 2016 5/13/2016 9:28:54 AM
Nordic Nanovector: First Quarter 2016 Results Presentation And Webcast 5/12/2016 11:16:56 AM
Nordic Nanovector Announces An Open Investigational New Drug Application For New Clinical Study Of Betalutin In Diffuse Large B-Cell Lymphoma 5/9/2016 9:47:44 AM
Nordic Nanovector To Present At BioEquity Europe on 11 May 2016 5/4/2016 10:23:47 AM
Nordic Nanovector: Share Capital Increase Registered 4/29/2016 1:27:51 PM